Concepedia

Qingsong Yin

QY

Statistics

Publications

4

Citations

88

H-Index

4

Active since

2014

Affiliations

Henan Cancer Hospital(Current)

Zhengzhou University

Qingsong Yin is an author at Henan Cancer Hospital specializing in oncology, molecular oncology, and microrna-mediated regulation.

ORCID

Publications per year

2014–2020

4

Publications

4

<p>The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia</p>

Shan Wang, Xiaojiao Wang, Sha Liu et al. · OncoTargets and Therapy · 2020 · 31 citations · Full text

, , +17

Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapy

Qingsong Yin, Chen Lin, Qianyu Li et al. · Cancer Cell International · 2014 · 25 citations · Full text

, , +16

LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15

Wenli Zuo, Keshu Zhou, Mei Deng et al. · Aging · 2020 · 21 citations · Full text

, , +16

RETRACTED ARTICLE: Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis

Qingsong Yin, Bo Liang, Ruihua Mi et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2019 · 11 citations

, , +17

1–4 of 4